首页> 外文期刊>Expert opinion on drug discovery >The reproducibility issue and preclinical academic drug discovery: educational and institutional initiatives fostering translation success
【24h】

The reproducibility issue and preclinical academic drug discovery: educational and institutional initiatives fostering translation success

机译:再现性问题和临床前学术药物发现:促进翻译成功的教育和机构举措

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Drug discovery depends critically upon published results from the academy. The reproducibility of preclinical research findings reported by academia in the peer-reviewed literature has been called into question, seriously jeopardizing the value of academic science for inventing therapeutics.
机译:简介:药物发现在很大程度上取决于该学院发表的成果。学术界在同行评议的文献中报告的临床前研究结果的可重复性已受到质疑,严重损害了学术科学在发明治疗方法方面的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号